Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001140361-11-036226
Filing Date
2011-07-08
Accepted
2011-07-08 16:13:38
Documents
1
Period of Report
2011-07-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 doc1.html 4  
1 FORM 4 doc1.xml 4 4084
  Complete submission text file 0001140361-11-036226.txt   5562
Mailing Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121
Business Address 9360 TOWNE CENTRE DR SUITE 110 SAN DIEGO CA 92121 6195522200
AMYLIN PHARMACEUTICALS INC (Issuer) CIK: 0000881464 (see all company filings)

EIN.: 330266089 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ICAHN CAPITAL LP 767 FIFTH AVENUE, SUITE 4700 NEW YORK NY 10153
Business Address
DENNER ALEXANDER J (Reporting) CIK: 0001361754 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19700 | Film No.: 11959485